Mantle cell lymphoma clinical trials

Introduction

Mantle cell lymphoma is a type of non-Hodgkin’s lymphoma. Mantle cell lymphoma starts in the mantle zone (a layer of tissue that surrounds many organs), hence its name. It can occur anywhere in the body but it most often occurs in the bones, stomach and intestines, or spleen. Worldwide, only about one percent of people with non-Hodgkin’s lymphomas have mantle cell lymphoma.

What is mantle cell lymphoma?

Mantle cell lymphoma is a type of non-Hodgkin’s lymphoma that affects the lymph nodes. It is most common in older adults, particularly men over the age of 60.

Mantle cell lymphoma can occur at any age, but it’s more common in men than women and usually begins after age 50. If you have symptoms that may be caused by mantle cell lymphoma or another disease, talk to your doctor about getting checked out as soon as possible.

What are the types of mantle cell lymphoma?

• Mantle cell lymphoma affects both men and women. It can be difficult to diagnose and treat, but there are clinical trials for mantle cell lymphoma that may help you live longer.
• Mantle cell Lymphoma is classified into two categories: indolent (slow growing) or aggressive (fast-growing). Your doctor will decide which category your disease falls under based on how quickly it grows and spreads in your body, as well as other factors such as age, weight and gender.
• Treatments for mantle cell Lymphoma include chemotherapy drugs or radiation therapy. Clinical trials also offer new treatments for people with mantle cell Lymphoma that could help them live longer than before!

How common is mantle cell lymphoma?

It accounts for about 1% of all cancers, and can occur in any age group but is more common in men than women.

Mantle cell lymphoma is not as common as other types of lymphomas such as Hodgkin’s disease or Burkitt’s lymphoma, which account for more than 20% of all cases each year.

Who gets mantle cell lymphoma?

Mantle cell lymphoma is a type of cancer that affects B cells, which are part of your immune system. It’s more common in older people than other types of lymphomas. Men are also more likely to get mantle cell lymphoma than women.

Mantle cell lymphoma can be caused by certain genetic conditions, including:

• Immunodeficiency disorders – These disorders affect how your body fights infection or responds to foreign substances (such as bacteria). They include X-linked agammaglobulinemia (XLA), Bruton agammaglobulinemia (Bruton’s disease) and Wiskott-Aldrich syndrome (WAS).
• Chronic infections – Infections that have lasted for many years may lead to chronic inflammation in some people who have no symptoms at first but then develop them later on. Examples include hepatitis B virus infection; cytomegalovirus infection; HIV/AIDS; Epstein-Barr virus infection (also called mononucleosis); tuberculosis; syphilis and leprosy

What causes mantle cell lymphoma?

Mantle cell lymphoma is a cancer of the immune system. The cause of mantle cell lymphoma is not known, but it may be triggered by an infection or other factors such as aging. It can also occur as part of certain genetic syndromes that affect the immune system, such as Down syndrome and chronic myelogenous leukemia (CML).

How is mantle cell lymphoma treated?

Mantle cell lymphoma is a type of lymphoma, which is a cancer that starts in the immune system.

Mantle cell lymphoma treatment may include:

• Chemotherapy — A drug that destroys cancer cells and shrinks tumors by stopping them from dividing and multiplying.
• Radiation therapy — A type of cancer treatment that uses high-energy rays to kill cancer cells and shrink tumors.
• Stem cell transplant — The process of removing blood-forming stem cells from your bone marrow or peripheral blood (blood circulating through your body) before giving you high doses of chemotherapy or radiation to destroy all remaining cancer cells; then replacing those stem cells so they can rebuild your immune system with healthy cells after treatment has ended.

Targeted therapy — Drugs designed to attack specific types of molecules found on the surface or inside tumors

What role does clinical research play in the treatment of mantle cell lymphoma?

Mantle cell lymphoma is a type of cancer that can be fatal if not treated. It’s also hard to treat, because the drugs currently used to treat mantle cell lymphoma have serious side effects.

Mantle cell lymphoma clinical trials are research studies that look at new ways to prevent, detect and treat diseases like mantle cell lymphoma. The goal is to find better treatments for people with mantle cell lymphoma or other types of cancer.

There are many clinical trials for mantle cell lymphoma.

There are many clinical trials for mantle cell lymphoma. A clinical trial is a way to test new treatments for mantle cell lymphoma, and it’s also a way to get treatment when there isn’t enough information yet on how effective a particular treatment might be. Some people with mantle cell lymphoma choose not to participate in clinical trials because they don’t want to take part in research or don’t want their information shared with others involved in the study (for example, researchers).